Krishnamurthy Varun K, Godby Richard C, Liu G R, Smith J Michael, Hiratzka Loren F, Narmoneva Daria A, Hinton Robert B
Division of Cardiology, the Heart Institute, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, MLC 7020, Cincinnati, OH, 45229, USA.
J Cardiovasc Transl Res. 2014 Dec;7(9):823-46. doi: 10.1007/s12265-014-9602-4. Epub 2014 Nov 20.
Aortic valve disease (AVD) and aortopathy are associated with substantial morbidity and mortality, representing a significant cardiovascular healthcare burden worldwide. These mechanobiological structures are morphogenetically related and function in unison from embryonic development through mature adult tissue homeostasis, serving both coordinated and distinct roles. In addition to sharing common developmental origins, diseases of the aortic valve and proximal thoracic aorta often present together clinically. Current research efforts are focused on identifying etiologic factors and elucidating pathogenesis, including genetic predisposition, maladaptive cell-matrix remodeling processes, and hemodynamic and biomechanical perturbations. Here, we review the impact of these processes as they pertain to translational research efforts, emphasizing the overlapping relationship of these two disease processes. The successful application of new therapeutic strategies and novel tissue bioprostheses for AVD and/or aortopathy will require an understanding and integration of molecular and biomechanical processes for both diseases.
主动脉瓣疾病(AVD)和主动脉病变与严重的发病率和死亡率相关,是全球心血管医疗保健的重大负担。这些机械生物学结构在形态发生上相关,从胚胎发育到成熟的成人组织稳态都协同发挥作用,发挥着协调且独特的作用。除了具有共同的发育起源外,主动脉瓣和胸段主动脉近端的疾病在临床上也常同时出现。当前的研究工作集中在确定病因和阐明发病机制,包括遗传易感性、适应性不良的细胞-基质重塑过程以及血流动力学和生物力学扰动。在此,我们综述这些过程对转化研究工作的影响,强调这两种疾病过程的重叠关系。成功应用针对AVD和/或主动脉病变的新治疗策略和新型组织生物假体将需要了解并整合这两种疾病的分子和生物力学过程。